Laserfiche WebLink
(a) Increase availability and distribution of naloxone and other drugs <br />that treat overdoses for first responders, overdose ,patients, <br />individuals with OUD and their friends and family Members, <br />individuals at high risk rerdpse, schools, comm ) Owigators <br />and outreach t'kerst.�t being released front (� or prison, <br />Or fif er members of mai 00blic, <br />_(b) ,Public health entities Rte` free naloxone to anyone Jh 1 <br />community. <br />(c) Training and educaftn regarding naloxone and ~ drugs 0 . <br />treat W4*rdoses for Abut' mpainderat overdue paU ' pati <br />taking opioids, families, school e4ftlmllt aopi Ups= ,ate <br />other members of the general public. <br />(d) Enable sch" nurses and other school stalt"F` 4M1d op <br />overdoses, and provide them with naloxone, t . <br />(e) Expand, improves or develop data tracking software and <br />applications for overdoses/naloxone revivals. <br />(f) Publicewducation relating to emergency responsep:ia <br />(g) Publiceducation relating to 11MUnuty,8nd Good Samat an laws. <br />(h) Educate first responders regardingwoxistence a :pperation of <br />Immunity and Good Samaritan laws <br />i Syringe service programs and other... , <br />to reduce harms associated with lnt�us dll use, 6cWinq <br />supplies, staffing spaces peer dopt services} referrals to <br />treatment, fentany becku , + ±t nnections to care, and the full range <br />of harm reduction and treatrnent services provided 100 these <br />programs. <br />j} Expand access to testi% and treatment I'w infectious diseases <br />such as HIV and Hepatitis O rasUlting from intravenous opioid use. <br />(k) Support mobile units that offer' i* provide referrals :. harm <br />reduction services., -treatment, re y OW )health . ; <br />other appropriate servlrs to persons t ds or paiitta <br />with ODU and anyfurring SUDfMH s. <br />Service Agreement 21 Agreement No.: <br />Indian Rive-GountV 6o8 dDi' <br />�dhrll: <br />68 <br />